EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles

Yuan Zou, Jing Zhang, Longmin Chen, Qianqian Xu, Sheng Yao, Hong Chen

Pharmaceutics · 18.03.2025 · 17 (3) · 388

DOI: 10.3390/pharmaceutics17030388 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 18.03.2025. Verfasst von Yuan Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Chen, Jing Zhang, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation within the central nervous system (CNS) is a primary characteristic of CNS diseases, such as Parkinson’s disease, Alzheimer’s disease (AD), amyotrophic lateral sclerosis, and mental disorders. The excessive activation of immune cells results in the massive release of pro-inflammatory cytokines, which subsequently induce neuronal death and accelerate the progression of neurodegeneration. Therefore, mitigating excessive neuroinflammation has emerged as a promising strategy for the treatment of CNS diseases. Despite advancements in drug discovery and the development of novel therapeutics, the effective delivery of these agents to the CNS remains a serious challenge due to the restrictive nature of the blood–brain barrier (BBB). This underscores the need to develop a novel drug delivery system. Recent studies have identified oral lipid nanoparticles (LNPs) as a promising approach to efficiently deliver drugs across the BBB and treat neurological diseases. This review aims to comprehensively summarize the recent advancements in the development of LNPs designed for the controlled delivery and therapeutic modulation of CNS diseases through oral administration. Furthermore, this review addresses the mechanisms by which these LNPs overcome biological barriers and evaluate their clinical implications and therapeutic efficacy in the context of oral drug delivery systems. Specifically, it focuses on LNP formulations that facilitate oral administration, exploring their potential to enhance bioavailability, improve targeting precision, and alleviate or manage the symptoms associated with a range of CNS diseases.

Schlagwörter

Stichwörter der Autor:innen

blood–brain barriercentral nervous system diseaseslipid nanoparticlesneuroinflammationoral delivery system

Autor:innen und Institutionen

  • Department of Rehabilitation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China.
  • Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan 430074, China.
  • Department of Respiratory and Critical Care Medicine, The Center for Biomedical Research, NHC Key Laboratory for Respiratory Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technol…
  • Department of Rheumatology and Immunology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China.

Förderung

  • Hong Chen
  • Jing Zhang
  • National Natural Science Foundation of China

Zitieren

APA

Zou, Y., Zhang, J., Chen, L., Xu, Q., Yao, S., & Chen, H. (2025). Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles. Pharmaceutics, 17(3), 388. https://doi.org/10.3390/pharmaceutics17030388

Vancouver

Zou Y, Zhang J, Chen L, Xu Q, Yao S, Chen H. Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles. Pharmaceutics. 2025;17(3):388. doi:10.3390/pharmaceutics17030388

BibTeX
@article{Zou2025,
  author = {Zou, Yuan and Zhang, Jing and Chen, Longmin and Xu, Qianqian and Yao, Sheng and Chen, Hong},
  title = {Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {388},
  doi = {10.3390/pharmaceutics17030388}
}
Kostenlos starten →